sodium polystyrene sulfonate

Generic: sodium polystyrene sulfonate

Labeler: chartwell rx, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name sodium polystyrene sulfonate
Generic Name sodium polystyrene sulfonate
Labeler chartwell rx, llc
Dosage Form POWDER, FOR SUSPENSION
Routes
ORAL RECTAL
Active Ingredients

sodium polystyrene sulfonate 4.1 meq/g

Manufacturer
Chartwell RX, LLC

Identifiers & Regulatory

Product NDC 62135-340
Product ID 62135-340_06fcec70-ae79-a194-e063-6394a90a6ffa
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA206815
Listing Expiration 2026-12-31
Marketing Start 2016-02-18

Pharmacologic Class

Established (EPC)
potassium binder [epc]
Mechanism of Action
potassium ion exchange activity [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62135340
Hyphenated Format 62135-340

Supplemental Identifiers

RxCUI
2101899
UPC
0362135340629 0362135340537 0362135340117
UNII
1699G8679Z
NUI
N0000178378 N0000175357

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name sodium polystyrene sulfonate (source: ndc)
Generic Name sodium polystyrene sulfonate (source: ndc)
Application Number ANDA206815 (source: ndc)
Routes
ORAL RECTAL
source: ndc

Resolved Composition

Strengths
  • 4.1 meq/g
source: ndc
Packaging
  • 10 BOTTLE in 1 BOX (62135-340-11) / 15 g in 1 BOTTLE
  • 453.6 g in 1 BOTTLE (62135-340-53)
  • 15 g in 1 BOTTLE (62135-340-62)
source: ndc

Packages (3)

Ingredients (1)

sodium polystyrene sulfonate (4.1 meq/g)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL", "RECTAL"], "spl_id": "06fcec70-ae79-a194-e063-6394a90a6ffa", "openfda": {"nui": ["N0000178378", "N0000175357"], "upc": ["0362135340629", "0362135340537", "0362135340117"], "unii": ["1699G8679Z"], "rxcui": ["2101899"], "spl_set_id": ["e910a2f9-07ee-4e8f-95bd-f124e1306ff7"], "pharm_class_epc": ["Potassium Binder [EPC]"], "pharm_class_moa": ["Potassium Ion Exchange Activity [MoA]"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 BOTTLE in 1 BOX (62135-340-11)  / 15 g in 1 BOTTLE", "package_ndc": "62135-340-11", "marketing_start_date": "20220720"}, {"sample": false, "description": "453.6 g in 1 BOTTLE (62135-340-53)", "package_ndc": "62135-340-53", "marketing_start_date": "20220720"}, {"sample": false, "description": "15 g in 1 BOTTLE (62135-340-62)", "package_ndc": "62135-340-62", "marketing_start_date": "20220720"}], "brand_name": "Sodium Polystyrene Sulfonate", "product_id": "62135-340_06fcec70-ae79-a194-e063-6394a90a6ffa", "dosage_form": "POWDER, FOR SUSPENSION", "product_ndc": "62135-340", "generic_name": "Sodium Polystyrene Sulfonate", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Sodium Polystyrene Sulfonate", "active_ingredients": [{"name": "SODIUM POLYSTYRENE SULFONATE", "strength": "4.1 meq/g"}], "application_number": "ANDA206815", "marketing_category": "ANDA", "marketing_start_date": "20160218", "listing_expiration_date": "20261231"}